216 related articles for article (PubMed ID: 26110015)
1. Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.
Simone TM; Higgins SP; Higgins CE; Lennartz MR; Higgins PJ
J Mol Genet Med; 2014 Oct; 8(3):. PubMed ID: 26110015
[No Abstract] [Full Text] [Related]
2. Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells.
Sironi L; Calvio AM; Arnaboldi L; Corsini A; Parolari A; de Gasparo M; Tremoli E; Mussoni L
Hypertension; 2001 Mar; 37(3):961-6. PubMed ID: 11244025
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
4. Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression.
Tsai SJ
Oncotarget; 2017 Dec; 8(68):113258-113268. PubMed ID: 29348904
[TBL] [Abstract][Full Text] [Related]
5. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator system and vascular disease.
Nicholl SM; Roztocil E; Davies MG
Curr Vasc Pharmacol; 2006 Apr; 4(2):101-16. PubMed ID: 16611153
[TBL] [Abstract][Full Text] [Related]
7. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
[TBL] [Abstract][Full Text] [Related]
8. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H; Koizumi F
Thromb Res; 1994 Apr; 74(2):163-8. PubMed ID: 8029817
[TBL] [Abstract][Full Text] [Related]
9. Effects of cadmium on the release of tissue plasminogen activator and plasminogen activator inhibitor type 1 from cultured human vascular smooth muscle cells and fibroblasts.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H
Toxicology; 1996 Jan; 106(1-3):179-85. PubMed ID: 8571389
[TBL] [Abstract][Full Text] [Related]
10. Prolonged cyclic strain impairs the fibrinolytic system in cultured vascular endothelial cells.
Ulfhammer E; Ridderstråle W; Andersson M; Karlsson L; Hrafnkelsdóttir T; Jern S
J Hypertens; 2005 Aug; 23(8):1551-7. PubMed ID: 16003182
[TBL] [Abstract][Full Text] [Related]
11. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi EL; Binder BR; Hamilton JA; McGrath K
Thromb Haemost; 1993 Sep; 70(3):469-74. PubMed ID: 8259551
[TBL] [Abstract][Full Text] [Related]
12. Characterization of signal transduction pathway in neurotropic action of angiotensin II in brain neurons.
Yang H; Wang X; Raizada MK
Endocrinology; 2001 Aug; 142(8):3502-11. PubMed ID: 11459796
[TBL] [Abstract][Full Text] [Related]
13. Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells.
Jin H; Lin J; Fu L; Mei YF; Peng G; Tan X; Wang DM; Wang W; Li YG
Biochem Cell Biol; 2007 Apr; 85(2):246-51. PubMed ID: 17534406
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
Feener EP; Northrup JM; Aiello LP; King GL
J Clin Invest; 1995 Mar; 95(3):1353-62. PubMed ID: 7883982
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of urokinase-like plasminogen activator and plasminogen activator inhibitor type 1 during the vascular remodeling associated with pulmonary thromboembolism.
Lang IM; Moser KM; Schleef RR
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):808-15. PubMed ID: 9598841
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor type 1: the two faces of the same coin.
Hertig A; Rondeau E
Curr Opin Nephrol Hypertens; 2004 Jan; 13(1):39-44. PubMed ID: 15090858
[TBL] [Abstract][Full Text] [Related]
17. The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.
Pieters M; Barnard SA; Loots DT; Rijken DC
PLoS One; 2017; 12(2):e0171271. PubMed ID: 28158230
[TBL] [Abstract][Full Text] [Related]
18. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
Chavakis T; Kanse SM; May AE; Preissner KT
Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845
[TBL] [Abstract][Full Text] [Related]
19. Persistent plasminogen activator inhibitor 1 gene expression in cardiac transplant recipients with idiopathic dilated cardiomyopathy.
Schäfer R; Krenn K; Gmeiner M; Abraham D; Aharinejad S
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1644-51. PubMed ID: 20392463
[TBL] [Abstract][Full Text] [Related]
20. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.
McCormack LJ; Nagi DK; Stickland MH; Mansfield MW; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
Diabetologia; 1996 Dec; 39(12):1512-8. PubMed ID: 8960834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
